Literature DB >> 21993636

Neisseria meningitidis: biology, microbiology, and epidemiology.

Nadine G Rouphael1, David S Stephens.   

Abstract

Neisseria meningitidis (the meningococcus) causes significant morbidity and mortality in children and young adults worldwide through epidemic or sporadic meningitis and/or septicemia. In this review, we describe the biology, microbiology, and epidemiology of this exclusive human pathogen. N.meningitidis is a fastidious, encapsulated, aerobic gram-negative diplococcus. Colonies are positive by the oxidase test and most strains utilize maltose. The phenotypic classification of meningococci, based on structural differences in capsular polysaccharide, lipooligosaccharide (LOS) and outer membrane proteins, is now complemented by genome sequence typing (ST). The epidemiological profile of N. meningitidis is variable in different populations and over time and virulence of the meningococcus is based on a transformable/plastic genome and expression of certain capsular polysaccharides (serogroups A, B, C, W-135, Y and X) and non-capsular antigens. N. meningitidis colonizes mucosal surfaces using a multifactorial process involving pili, twitching motility, LOS, opacity associated, and other surface proteins. Certain clonal groups have an increased capacity to gain access to the blood, evade innate immune responses, multiply, and cause systemic disease. Although new vaccines hold great promise, meningococcal infection continues to be reported in both developed and developing countries, where universal vaccine coverage is absent and antibiotic resistance increasingly more common.

Entities:  

Mesh:

Year:  2012        PMID: 21993636      PMCID: PMC4349422          DOI: 10.1007/978-1-61779-346-2_1

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  130 in total

1.  Uncloaking the meningococcus: dynamics of carriage and disease.

Authors:  D S Stephens
Journal:  Lancet       Date:  1999-03-20       Impact factor: 79.321

2.  The sensitivity of meningococci to sulfadiazine.

Authors:  E B SCHOENBACH; J J PHAIR
Journal:  Am J Hyg       Date:  1948-03

3.  The N-domain of the human CD66a adhesion molecule is a target for Opa proteins of Neisseria meningitidis and Neisseria gonorrhoeae.

Authors:  M Virji; S M Watt; S Barker; K Makepeace; R Doyonnas
Journal:  Mol Microbiol       Date:  1996-12       Impact factor: 3.501

4.  Comparative genomics of Neisseria meningitidis: core genome, islands of horizontal transfer and pathogen-specific genes.

Authors:  Julie C Dunning Hotopp; Renata Grifantini; Nikhil Kumar; Yih Ling Tzeng; Derrick Fouts; Elisabetta Frigimelica; Monia Draghi; Marzia Monica Giuliani; Rino Rappuoli; David S Stephens; Guido Grandi; Hervé Tettelin
Journal:  Microbiology       Date:  2006-12       Impact factor: 2.777

Review 5.  The role of porins in neisserial pathogenesis and immunity.

Authors:  Paola Massari; Sanjay Ram; Heather Macleod; Lee M Wetzler
Journal:  Trends Microbiol       Date:  2003-02       Impact factor: 17.079

6.  MeNZB: a safe and highly immunogenic tailor-made vaccine against the New Zealand Neisseria meningitidis serogroup B disease epidemic strain.

Authors:  Philipp Oster; Diana Lennon; Jane O'Hallahan; Kim Mulholland; Stewart Reid; Diana Martin
Journal:  Vaccine       Date:  2005-03-18       Impact factor: 3.641

7.  Identification of nasopharyngeal carriage of an outbreak strain of Neisseria meningitidis by pulsed-field gel electrophoresis versus phenotypic methods.

Authors:  L Bevanger; K Bergh; G Gisnås; D A Caugant; L O Frøholm
Journal:  J Med Microbiol       Date:  1998-11       Impact factor: 2.472

8.  TLR4-dependent adjuvant activity of Neisseria meningitidis lipid A.

Authors:  Susu Zughaier; Liana Steeghs; Peter van der Ley; David S Stephens
Journal:  Vaccine       Date:  2007-04-02       Impact factor: 3.641

9.  Population-based analysis of meningococcal disease mortality in the United States: 1990-2002.

Authors:  Akbar Sharip; Frank Sorvillo; Matthew D Redelings; Laurene Mascola; Matthew Wise; Dao M Nguyen
Journal:  Pediatr Infect Dis J       Date:  2006-03       Impact factor: 2.129

10.  Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection.

Authors:  Stephen E Girardin; Ivo G Boneca; Jérôme Viala; Mathias Chamaillard; Agnès Labigne; Gilles Thomas; Dana J Philpott; Philippe J Sansonetti
Journal:  J Biol Chem       Date:  2003-01-13       Impact factor: 5.157

View more
  103 in total

1.  Safety and immunogenocity of a novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C-tetanus-toxoid conjugate vaccine in healthy Chinese children aged 6 months to 5 years old.

Authors:  Jian-li Hu; Hong Tao; Jing-xin Li; Wei-ming Dai; Bin Song; Jin-fang Sun; Pei Liu; Jie Tang; Wen-yu Liu; Shi-yuan Wang; Feng-cai Zhu
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 2.  Pre-admission antibiotics for suspected cases of meningococcal disease.

Authors:  Thambu D Sudarsanam; Priscilla Rupali; Prathap Tharyan; Ooriapadickal Cherian Abraham; Kurien Thomas
Journal:  Cochrane Database Syst Rev       Date:  2017-06-14

Review 3.  Meningococcal quadrivalent tetanus toxoid conjugate vaccine (MenACWY-TT, Nimenrix™): A review of its immunogenicity, safety, co-administration, and antibody persistence.

Authors:  Aia Assaf-Casals; Ghassan Dbaibo
Journal:  Hum Vaccin Immunother       Date:  2016-02-22       Impact factor: 3.452

Review 4.  Review of meningococcal vaccines with updates on immunization in adults.

Authors:  Yorgo C Zahlanie; Moza M Hammadi; Soha T Ghanem; Ghassan S Dbaibo
Journal:  Hum Vaccin Immunother       Date:  2014-02-05       Impact factor: 3.452

5.  Size-Controlled Chemoenzymatic Synthesis of Homogeneous Oligosaccharides of Neisseria meningitidis W Capsular Polysaccharide.

Authors:  Riyao Li; Hai Yu; Saddam M Muthana; Darón I Freedberg; Xi Chen
Journal:  ACS Catal       Date:  2020-02-07       Impact factor: 13.084

Review 6.  A deeper mining on the protein composition of VA-MENGOC-BC®: An OMV-based vaccine against N. meningitidis serogroup B and C.

Authors:  Yordanka Masforrol; Jeovanis Gil; Darien García; Jesús Noda; Yassel Ramos; Lázaro Betancourt; Osmany Guirola; Sonia González; Boris Acevedo; Vladimir Besada; Osvaldo Reyes; Luis Javier González
Journal:  Hum Vaccin Immunother       Date:  2017-10-30       Impact factor: 3.452

Review 7.  Challenges and opportunities for meningococcal vaccination in the developing world.

Authors:  Rouba Shaker; Danielle Fayad; Ghassan Dbaibo
Journal:  Hum Vaccin Immunother       Date:  2018-02-23       Impact factor: 3.452

8.  Antibody to a conserved antigenic target is protective against diverse prokaryotic and eukaryotic pathogens.

Authors:  Colette Cywes-Bentley; David Skurnik; Tanweer Zaidi; Damien Roux; Rosane B Deoliveira; Wendy S Garrett; Xi Lu; Jennifer O'Malley; Kathryn Kinzel; Tauqeer Zaidi; Astrid Rey; Christophe Perrin; Raina N Fichorova; Alexander K K Kayatani; Tomas Maira-Litràn; Marina L Gening; Yury E Tsvetkov; Nikolay E Nifantiev; Lauren O Bakaletz; Stephen I Pelton; Douglas T Golenbock; Gerald B Pier
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-28       Impact factor: 11.205

Review 9.  The interplay between Siglecs and sialylated pathogens.

Authors:  Yung-Chi Chang; Victor Nizet
Journal:  Glycobiology       Date:  2014-07-04       Impact factor: 4.313

10.  Antigenic Variation in Bacterial Pathogens.

Authors:  Guy H Palmer; Troy Bankhead; H Steven Seifert
Journal:  Microbiol Spectr       Date:  2016-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.